Publicaciones en las que colabora con María Carmen Chillón (19)

2023

  1. Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study

    Blood Cancer Journal

2022

  1. Interlaboratory Analytical Validation of a Next-Generation Sequencing Strategy for Clonotypic Assessment and Minimal Residual Disease Monitoring in Multiple Myeloma

    Archives of pathology & laboratory medicine, Vol. 146, Núm. 7, pp. 862-871

2020

  1. Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma

    Blood, Vol. 135, Núm. 26, pp. 2375-2387

  2. Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

    Blood Cancer Journal, Vol. 10, Núm. 10

2018

  1. Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy

    Modern Pathology, Vol. 31, Núm. 8, pp. 1318-1331

2017

  1. A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma

    Journal of Molecular Diagnostics, Vol. 19, Núm. 1, pp. 99-106

2014

  1. Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by BCR-ABL1 fusion gene

    American Journal of Hematology, Vol. 89, Núm. 3, pp. 288-294

2012

  1. Flow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemia

    Leukemia, Vol. 26, Núm. 9, pp. 1976-1985

2010

  1. Mapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arrays

    PLoS ONE, Vol. 5, Núm. 10

2008

  1. Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma

    British Journal of Haematology, Vol. 141, Núm. 2, pp. 212-215

2004

  1. Atypical fluorescence in situ hybridisation pattern in chronic myeloid leukaemia due to cryptic insertion of BCR at 9q34 (multiple letters) [1]

    Leukemia

  2. Reply to Wan et al

    Leukemia

2003

  1. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: Incidence and underlying genetic abnormalities

    Leukemia, Vol. 17, Núm. 6, pp. 1124-1129

2001

  1. Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

    Bone Marrow Transplantation, Vol. 28, Núm. 7, pp. 665-672

  2. Molecular characterization of acute myeloblastic leukemia according to the new WHO classification: A different distribution in Central-West Spain

    Haematologica, Vol. 86, Núm. 2, pp. 162-166

2000

  1. Two new 3' PML breakpoints in t(15;17)(q22;q21)-positive acute promyelocytic leukemia

    Genes Chromosomes and Cancer, Vol. 27, Núm. 1, pp. 35-43

1999

  1. Heteroduplex analysis of VDJ amplified segments from rearranged IgH genes for clonality assessments in B-cell non-Hodgkin's lymphoma. A comparison between different strategies

    Haematologica, Vol. 84, Núm. 9, pp. 779-784

  2. Low frequency of the TEL/AML1 fusion gene in acute lymphoblastic leukaemia in Spain

    British Journal of Haematology, Vol. 107, Núm. 3, pp. 667-669

  3. The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARα gene rearrangements

    Haematologica, Vol. 84, Núm. 5, pp. 405-412